Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600118665Phase 4Not yet recruiting
Phase 4 trial of ciprofol (2 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoints: Loss of consciousness effect-site concentration and Effect-site concentration at 1 minute prior to tracheal intubation. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600118665.